SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-16-009526
Filing Date
2016-11-07
Accepted
2016-11-07 16:30:34
Documents
3
Period of Report
2016-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvls_currentfolio8k.htm 8-K 27802
2 EX-99.1 nvls_ex991.htm EX-99.1 126871
3 GRAPHIC nvlsex991001.jpg GRAPHIC 9135
  Complete submission text file 0001558370-16-009526.txt   168512
Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700
Nivalis Therapeutics, Inc. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 161978510
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1